Pomdoctor Reports Strong FY2025 Growth

Pomdoctor Reports Strong FY2025 Growth
Pomdoctor Limited has announced its full year 2025 financial results, demonstrating solid revenue expansion despite margin compression challenges. The company reported net revenue of RMB399.9 million, representing a year-over-year increase of 16.7 percent, indicating sustained demand for its products and services in the competitive market. Gross profit grew to RMB52.4 million, up 9.6 percent compared to the prior year period. However, the gross margin contracted to 13.1 percent from the previous year's levels, suggesting rising operational costs and input expenses that have outpaced revenue growth. This margin pressure reflects broader industry challenges including increased competition and supply chain complexities. The divergence between revenue growth of 16.7 percent and gross profit growth of 9.